Autres langues InDex Pharmaceuticals Holding AB

Actions

INDEX

SE0008966295

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:38 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,329 ^SEK	0,00 %		+0,61 %	+28,52 %

05/04	Index Pharmaceuticals Holding AB (Publ) annonce la démission de membres de son conseil d'administration	CI
26/03	Le PDG et le directeur financier d'InDex Pharmaceuticals quittent leurs fonctions alors que l'entreprise cesse ses activités	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

InDex Pharmaceuticals provides a company update	08/04
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2023	08/04
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)	05/04
Index Pharmaceuticals Holding AB Announces Board Resignations	05/04
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease	26/03
CEO and CFO both to leave InDex Pharmaceuticals	26/03
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO	26/03
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024	26/03
InDex Pharmaceuticals Holding AB Announce Resignation of Johan Giléus as CFO, Effective September 26, 2024	26/03
InDex Pharmaceuticals Launches Strategic Review Amid Decision to Stop Cobitolimod Development	27/02
InDex Pharmaceuticals provides an update on company's future	26/02
InDex Pharmaceuticals discontinues the development of cobitolimod	26/02
InDex Pharmaceuticals Holding AB Discontinues the Development of Cobitolimod	26/02
InDex Pharmaceuticals Holding AB (publ) year-end report 2023	21/02
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	21/02
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/02
InDex Pharmaceuticals announces expected cash balance per March 31, 2024	19/01
InDex Pharmaceuticals Holding AB interim report January-September 2023	29/11
InDex Pharmaceuticals Q3 2023 - Uncertain future post discontinuation of CONCLUDE	29/11
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues InDex Pharmaceuticals Holding AB

Actions

INDEX

SE0008966295

Autres langues

Filtres